The 2024-25 annual report from the Pan-Canadian Cancer Genomics Community of Practice showcases achievements throughout the year and details next steps toward equitable, standardized biomarker testing.
News Type: Member/partner updates
Members of the Pan-Canadian Cancer Genomics Community of Practice contributed to the development of a consensus-based assessment framework to support the standardized, efficient, and transparent evaluation of molecular, genetic, and genomic biomarkers in cancer care in Canada.
The pan-Canadian Quality Assurance in Radiopharmaceutical Therapy (pCQRT) advisory committee — one of CAPCA’s standing committees — recently met to set its upcoming priorities.
This marks the committee’s first multi-year work plan and outlines how pCQRT will help support safe,…